| http://www.w3.org/ns/prov#value | - Given the issues raised by the investigation of Rebarber et al, the intent of the current investigation was to evaluate the frequency of abnormal glucose testing and GDM among women receiving 17??-hydroxyprogesterone caproate and compare the findings with those of a group of 17??-hydroxyprogesterone caproate???unexposed controls matched by maternal age and body mass index (BMI).
|
